MarketWatch2d
Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
Vertex Pharmaceuticals Faces Integration Challenges in Alpine Acquisition
Vertex Pharmaceuticals Inc. (VRTX) has disclosed a new risk, in the Innovation / R&D category. Vertex Pharmaceuticals Inc. faces ...
Vertex Pharmaceuticals: Strong Execution Continued In Q3 But The Valuation Reflects It
Vertex Pharmaceuticals continues to excel with strong Q3 results and promising clinical progress, but its valuation may ...
Business Insider6d
Scotiabank Reaffirms Their Hold Rating on Vertex Pharmaceuticals (VRTX)
In a report released today, Greg Harrison from Scotiabank maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report), with a price target of $486.00. The company’s shares closed ...